[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-05", "acceptance_datetime": "2025-11-05T13:00:56Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001936258", "sic": "2834", "tickers": ["NAMS", "NAMSW"], "company_name": "NewAmsterdam Pharma Co N.V.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-265796", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-265796/files/nams-20250930_htm.xml", "financials": {"income_statement": {"net_income_loss_attributable_to_parent": {"value": -72005000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -72005000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -72005000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "depreciation_and_amortization": {"value": 125000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "income_loss_from_continuing_operations_after_tax": {"value": -72005000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 72353000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "revenues": {"value": 348000, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "selling_general_and_administrative_expenses": {"value": 24520000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_expenses": {"value": 55491000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 119000266.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.61, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "research_and_development": {"value": 30971000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 119000266.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -55143000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.61, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -72005000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 72353000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -71692000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -71692000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -71692000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"noncurrent_assets": {"value": 54099000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 323000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 58272000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 85000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 58357000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 728070000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 53776000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 54640000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 728070000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 3632000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 786427000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 786427000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 732328000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 5892000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 2506000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -24371000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -24371000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 5892000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 2506000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -32769000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -32769000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-06", "acceptance_datetime": "2025-08-06T11:00:20Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001936258", "sic": "2834", "tickers": ["NAMS", "NAMSW"], "company_name": "NewAmsterdam Pharma Co N.V.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-103521", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-103521/files/nams-20250630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 3425000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -193382000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -37671000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -193382000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 3425000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -159136000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -159136000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -37671000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"operating_income_loss": {"value": -35635000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -17364000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 118556492.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "depreciation_and_amortization": {"value": 107000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -17364000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -17364000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 19145000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 36509000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 36509000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "research_and_development": {"value": 27516000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 118556492.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_before_tax": {"value": -17364000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -0.15, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -0.15, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_parent": {"value": -17364000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 54780000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "selling_general_and_administrative_expenses": {"value": 27264000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -17471000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -17471000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -17471000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"equity_attributable_to_parent": {"value": 778497000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 5895000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 44950000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 769850000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 36512000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 30617000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 815112000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 815112000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 778497000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 36615000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 45262000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 312000, "unit": "USD", "label": "Fixed Assets", "order": 320}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-08", "acceptance_datetime": "2025-05-08T12:00:20Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001936258", "sic": "2834", "tickers": ["NAMS", "NAMSW"], "company_name": "NewAmsterdam Pharma Co N.V.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-066413", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-066413/files/nams-20250331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 6519000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -36468000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -27094000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 2855000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 2855000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -27094000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -36468000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 6519000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -39560000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -39560000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -39560000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.34, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -68925000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": 116124941.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "benefits_costs_expenses": {"value": 42505000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 42505000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -39527000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 44751000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "selling_general_and_administrative_expenses": {"value": 27152000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss": {"value": -39527000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 2978000.0, "unit": "USD", "label": "Revenues", "order": 100}, "depreciation_and_amortization": {"value": 113000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "income_loss_from_continuing_operations_before_tax": {"value": -39527000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -39527000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_average_shares": {"value": 116124941.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 71903000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.34, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -39527000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "balance_sheet": {"other_current_liabilities": {"value": 34826000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 6087000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 871000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 777363000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 777363000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 1109000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 818413000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 40913000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 817304000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 238000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 818413000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 41050000.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001936258", "sic": "2834", "tickers": ["NAMS", "NAMSW"], "company_name": "NewAmsterdam Pharma Co N.V.", "financials": {"balance_sheet": {"assets": {"value": 864620000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 757500000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 106918000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 863413000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 4744000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 757500000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 107120000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 965000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 864620000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 242000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 102174000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 1207000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 202000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 45000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -92132000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -92132000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -62179000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -62179000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 456611000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 356951000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -37481000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 356951000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 456611000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -37481000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -92177000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "benefits_costs_expenses": {"value": 104949000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_earnings_per_share": {"value": -0.95, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "basic_average_shares": {"value": 1691193.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 56001000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -92177000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": 1691193.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "revenues": {"value": 12772000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 104949000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -92177000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "selling_general_and_administrative_expenses": {"value": 21106000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -92177000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -43229000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_earnings_per_share": {"value": -0.95, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_after_tax": {"value": -92177000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 34895000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-06", "acceptance_datetime": "2024-11-06T13:00:20Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001936258", "sic": "2834", "tickers": ["NAMS", "NAMSW"], "company_name": "NewAmsterdam Pharma Co N.V.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-121828", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-121828/files/nams-20240930_htm.xml", "financials": {"balance_sheet": {"fixed_assets": {"value": 231000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 378862000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 60329000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 34216000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 1086000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 437874000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 1317000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 19074000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 439191000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 439191000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 41255000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 7039000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 378862000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -16647000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -16647000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -16647000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -16647000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "benefits_costs_expenses": {"value": 45759000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -16647000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 54114000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -25003000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -16647000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -16648000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_tax_expense_benefit": {"value": -1000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "research_and_development": {"value": 35702000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -16647000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.18, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "diluted_average_shares": {"value": 94754140.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "selling_general_and_administrative_expenses": {"value": 18412000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "costs_and_expenses": {"value": 45759000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -0.18, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 29111000.0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_average_shares": {"value": 94754140.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}}}}, {"start_date": "2024-03-31", "end_date": "2024-06-30", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001936258", "sic": "2834", "tickers": ["NAMS", "NAMSW"], "company_name": "NewAmsterdam Pharma Co N.V.", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 387439000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": -387439000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": -387439000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 387439000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -39007000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -39007000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -39007000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-08", "acceptance_datetime": "2024-05-08T20:30:34Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001936258", "sic": "2834", "tickers": ["NAMS", "NAMSW"], "company_name": "NewAmsterdam Pharma Co N.V.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-055767", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-055767/files/nams-20240331_htm.xml", "financials": {"balance_sheet": {"noncurrent_assets": {"value": 641000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 524000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 411803000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 487822000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 101000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 59726000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 411803000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_prepaid_expenses": {"value": 16000, "unit": "USD", "label": "Non-current Prepaid Expenses", "order": 340}, "other_current_liabilities": {"value": 51190000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 76660000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 8536000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 488463000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 488463000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -93767000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -93767000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -93767000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"benefits_costs_expenses": {"value": 95168000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 56883000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_average_shares": {"value": 88380230.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "diluted_earnings_per_share": {"value": -1.06, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -55482000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -93767000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -93767000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": -1.06, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -93767000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -93767000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 95168000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "research_and_development": {"value": 42430000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -93767000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 88380230.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "selling_general_and_administrative_expenses": {"value": 14453000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "revenues": {"value": 1401000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -54602000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -54602000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 143193000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -385000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 198180000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 143193000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 198180000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -385000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001936258", "sic": "2834", "tickers": ["NAMS", "NAMSW"], "company_name": "NewAmsterdam Pharma Co N.V.", "financials": {"balance_sheet": {"accounts_payable": {"value": 16923000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 288393000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 306000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 58704000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 8807000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 32974000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 347097000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 49897000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_noncurrent_assets": {"value": 225000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 346791000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 347097000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 288393000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 46000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_prepaid_expenses": {"value": 35000, "unit": "USD", "label": "Non-current Prepaid Expenses", "order": 340}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}}}]